-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Turnstone Biologics Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2023.
- Turnstone Biologics Corp. Operating Income (Loss) for the quarter ending June 30, 2024 was -$22.1M, a 0.94% decline year-over-year.
- Turnstone Biologics Corp. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$79.5M.
- Turnstone Biologics Corp. annual Operating Income (Loss) for 2023 was -$59M, a 86.7% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)